skip to Main Content
February 27, 2020 12:30 - 1:30 PM ET

What’s Next for Medicaid Drug Pricing?

  • This page as PDF


View the webinar recording to learn more about the latest policy, pricing, and reimbursement challenges in Medicaid.

Drug pricing has become one of the biggest areas of concern for Americans. As both federal and state government spending on Medicaid programs has grown exponentially in recent years, states are taking action to contain drug costs in Medicaid through traditional methods like utilization management as well as through innovative methods like value-based contracts. Increasingly, states are using the flexibilities offered to Medicaid programs to reimagine the way prescription drugs are managed and study new methods of payment for the latest treatment modalities that offer meaningful clinical impact.

On February 27, 2020, Avalere experts discussed the latest policy, pricing, and reimbursement challenges in Medicaid. They reviewed the ways prescription drugs are managed in the Medicaid program, the questions states are asking, and what comes next.

Key Topics

• Medicaid prescription drug budgeting and management
• Capped funding, rebates, and alternative payment models
• Payment for new high-priced treatments that promise to cure disabling conditions
• Option for states to have closed formularies for healthy adult populations


Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Jay Jackson , Principal, Commercialization & Regulatory Strategy

Jay Jackson conducts evidence-based assessments of the regulatory and policy environments for approval of and market access for medical products.

Tiernan Meyer , Principal, Policy

Tiernan Meyer supports Avalere clients in analytic and strategic engagements focused on Medicaid, Medicare Part D, state health policy trends, and the impact of federal health reform.

Margaret Scott , Associate Principal, Policy

Margaret Scott supports clients with Medicaid drug policy and pricing.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about State Policy
Please enter your email address to be notified when new State Policy insights are published.

Back To Top